Study to Evaluate the Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases
Condition: Primary Immune Deficiency Disorder Intervention: Biological: Octanorm Sponsor: Octapharma Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials